Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-05-10T21:14:35.665Z Has data issue: false hasContentIssue false
  • English
  • Français

Hair cortisol concentration in anxiety disorders: exploration of relationships with symptom severity and inflammatory markers

Published online by Cambridge University Press:  15 October 2020

Hesham Y. Elnazer Open the ORCID record for Hesham Y. Elnazer [Opens in a new window] ,
Laurie C. K. Lau ,
Hugo Amaro  and
David S. Baldwin
Hesham Y. Elnazer*
Affiliation:
Department of Liaison Psychiatry, St Richard’s Hospital, Sussex Partnership NHS Foundation Trust, Chichester, UK Clinical and Experimental Sciences (CNS and Psychaitry), Faculty of Medicine, University of Southampton, Southampton, UK
Laurie C. K. Lau
Affiliation:
Clinical and Experimental Sciences (CNS and Psychaitry), Faculty of Medicine, University of Southampton, Southampton, UK
Hugo Amaro
Affiliation:
Southern Health NHS Foundation Trust, Southampton, UK
David S. Baldwin
Affiliation:
Clinical and Experimental Sciences (CNS and Psychaitry), Faculty of Medicine, University of Southampton, Southampton, UK Southern Health NHS Foundation Trust, Southampton, UK
*
Author for correspondence: Hesham Y Elnazer, Email: hye1c13@soton.ac.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Hair cortisol concentration (HCC) can be used to periodically assess hypothalamic–pituitary–adrenal (HPA) axis function, and appears correlated with prolonged exposure to stress.

Methods:

Serial assessment (at Baseline, Week 6 and Week 12) of participants (n = 35) with anxiety disorders by psychopathological rating scales, with assays of HCC and levels of peripheral anti- and pro-inflammatory cytokines. Patients underwent antidepressant treatment for an initial 6 weeks, followed by cyclo-oxygenase inhibitor-2 (COX-2) inhibitor (celecoxib) augmentation or ‘treatment as usual’ for a further 6 weeks.

Results:

At Baseline (n = 35), HCC was elevated in patients with single-episode but not recurrent-episode anxiety disorders, mean IL-12p70 levels were low, and mean TNF-α levels were elevated. Following 6 weeks of antidepressant treatment (n = 33), mean HCC was within the normal range but mean IL-2 level was low. Celecoxib augmentation (n = 18) was associated with a reduction in anxiety symptoms and normalisation of mean IL-2 levels.

Limitations:

Small sample size. Not all participants were assessed at all time points.

Conclusion:

Serial assessment of HCC is practicable in patients with anxiety disorders. These preliminary findings warrant further investigation in larger samples.

Keywords

anxiety disordershydrocortisonehypothalamo–hypophyseal systemhairinflammation
Type
Original Article
Information
Acta Neuropsychiatrica , Volume 33 , Issue 2 , April 2021 , pp. 104 - 110
Check for updates
Copyright
© Scandinavian College of Neuropsychopharmacology 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abbasi, S-H, Hosseini, F, Modabbernia, A, Ashrafi, M and Akhondzadeh, S (2012) Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study. Journal of Affective Disorders 141(2–3), 308–314.CrossRefGoogle ScholarPubMed
Psychiatric Association American (2013) Diagnostic and statistical manual of mental disorders (DSM-5). Washington: American Psychiatric Publishing.Google Scholar
Barrett, KE and Ganong, WF (2016) Ganong’s Review of Medical Physiology, 25th Edn. New York: McGraw-Hill Medical.Google Scholar
Chesnokova, V, Pechnick, RN and Wawrowsky, K (2016) Chronic peripheral inflammation, hippocampal neurogenesis, and behavior. Brain, Behavior, and Immunity 58, 1–8.CrossRefGoogle Scholar
Cook, TJ and Spector, AR (1964) Excretion of intravenously administered radioactive hydrocortisone in skin surface lipids**from the Section of Dermatology, Department of Medicine, The University of Chicago, Chicago, Illinois. Journal of Investigative Dermatology 43(5), 413–414.CrossRefGoogle Scholar
Costello, H, Gould, RL, Abrol, E and Howard, R (2019) Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open [online] 9(7), e027925.CrossRefGoogle ScholarPubMed
Dettenborn, L, Muhtz, C, Skoluda, N, Stalder, T, Steudte, S, Hinkelmann, K, Kirschbaum, C and Otte, C (2012) Introducing a novel method to assess cumulative steroid concentrations: increased hair cortisol concentrations over 6 months in medicated patients with depression. Stress 15, 348–353.CrossRefGoogle ScholarPubMed
Elnazer, HY and Baldwin, DS (2014) Investigation of Cortisol levels in patients with anxiety disorders: a structured review. Current Topics in Behavioral Neurosciences 18, 191–216.CrossRefGoogle ScholarPubMed
Gao, W, Zhong, P, Xie, Q, Wang, H, Jin, J, Deng, H and Lu, Z (2014) Temporal features of elevated hair cortisol among earthquake survivors. Psychophysiology, 51(4), 319–326.CrossRefGoogle ScholarPubMed
Guy, W (1976) ECDEU Assessment Manual for Psychopharmacology. Rockville (MD): National Institute of Mental Health. pp. 217–222, 313–331.Google Scholar
Herane Vives, A, De Angel, V, Papadopoulos, A, Strawbridge, R, Wise, T, Young, AH, Arnone, D and Cleare, AJ (2015) The relationship between cortisol, stress and psychiatric illness: New insights using hair analysis. Journal of Psychiatric Research 70, 38–49.CrossRefGoogle ScholarPubMed
Hou, R, Garner, M, Holmes, C, Osmond, C, Teeling, J, Lau, L and Baldwin, DS (2017) Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain, Behavior, and Immunity 62, 212–218.CrossRefGoogle ScholarPubMed
Iyengar, RL, Gandhi, S, Aneja, A, Thorpe, K, Razzouk, L, Greenberg, J, Mosovich, S and Farkouh, ME (2013) NSAIDs are associated with lower depression scores in patients with osteoarthritis. The American Journal of Medicine [online] 126(11), 1017.e11–1017.e18.CrossRefGoogle ScholarPubMed
Kao, K, Doan, SN, St. John, AM, Meyer, JS and Tarullo, AR (2018) Salivary cortisol reactivity in pre-schoolers is associated with hair cortisol and behavioural problems. Stress, 21(1), 28–35.CrossRefGoogle Scholar
Kapoor, A, Schultz-Darken, N and Ziegler, TE (2018) Radiolabel validation of cortisol in the hair of rhesus monkeys. Psychoneuroendocrinology, 97, 190–195.CrossRefGoogle ScholarPubMed
Kristensen, SK, Larsen, SC, Olsen, NJ, Fahrenkrug, J and Heitmann, BL (2017) Hair dyeing, hair washing and hair cortisol concentrations among women from the healthy start study. Psychoneuroendocrinology 77, 182–185.CrossRefGoogle ScholarPubMed
Loussouarn, G (2001) African hair growth parameters. British Journal of Dermatology [online] 145(2), 294–297.CrossRefGoogle ScholarPubMed
Luo, H, Hu, X, Liu, X, Ma, X, Guo, W, Qiu, C, Wang, Y, Wang, Q, Zhang, X, Zhang, W, Hannum, G, Zhang, K, Liu, X and Li, T (2012) Hair cortisol level as a biomarker for altered hypothalamic-pituitary-adrenal activity in female adolescents with posttraumatic stress disorder after the 2008 Wenchuan earthquake. Biological Psychiatry 72, 65–69.CrossRefGoogle ScholarPubMed
Manenschijn, L, Koper, JW and van den Akker, EL (2012) A novel tool in the diagnosis and follow-up of (cyclic) Cushing’s syndrome: measurement of long-term cortisol in scalp hair. Journal of Clinical Endocrinology and Metabolism 97(10), E1836–E1843.CrossRefGoogle ScholarPubMed
McGahuey, A, Gelenberg, AJ and Cin, C (2000) The Arizona Sexual Experience Scale (ASEX): reliability and Validity. Journal of Sex & Marital Therapy [online] 26(1), 25–40.Google ScholarPubMed
Ouellette, SJ, Russell, E, Kryski, KR, Sheikh, HI, Singh, SM, Koren, G and Hayden, EP (2015) Hair cortisol concentrations in higher and lower-stress mother-daughter dyads: A pilot study of associations and moderators. Developmental Psychobiology 57(5), 519–534.CrossRefGoogle ScholarPubMed
Price, J, Cole, V, Doll, H and Goodwin, GM (2012) The Oxford Questionnaire on the Emotional Side-effects of Antidepressants (OQuESA): development, validity, reliability and sensitivity to change. Journal of Affective Disorders 140(1), 66–74.CrossRefGoogle ScholarPubMed
Raul, J-S, Cirimele, V, Ludes, B and Kintz, P (2004) Detection of physiological concentrations of cortisol and cortisone in human hair. Clinical Biochemistry 37, 1105–1111.CrossRefGoogle ScholarPubMed
Russell, E, Koren, G, Rieder, M and Van Uum, S (2012) Hair cortisol as a biological marker of chronic stress: Current status, future directions and unanswered questions. Psychoneuroendocrinology 37(5), 589–601.CrossRefGoogle ScholarPubMed
Schütz, H, Ahrens, B, Erdmann, F and Rochholz, G (1993) The detection of drugs and other foreign substances in hair. Pharmazie in Unserer Zeit 2, 65–78.CrossRefGoogle Scholar
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, Hergueta, T, Baker, R and Dunbar, GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59(Suppl 20), 22–33; quiz 34–57.Google ScholarPubMed
Short, SJ, Stalder, T, Marceau, K, Entringer, S, Moog, NK, Shirtcliff, EA, Wadhwa, PD and Buss, C (2016) Correspondence between hair cortisol concentrations and 30-day integrated daily salivary and weekly urinary cortisol measures. Psychoneuroendocrinology [online] 71, 12–18.CrossRefGoogle ScholarPubMed
Skoluda, N, Dettenborn, L, Stalder, T and Kirschbaum, C (2012) Elevated hair cortisol concentrations in endurance athletes. Psychoneuroendocrinology 37(5), 611–617.CrossRefGoogle ScholarPubMed
Stalder, T, Steudte-Schmiedgen, S, Alexander, N, Klucken, T, Vater, A, Wichmann, S and Miller, R (2017) Stress-related and basic determinants of hair cortisol in humans: a meta-analysis. Psychoneuroendocrinology 77, 261–274.CrossRefGoogle ScholarPubMed
Steudte, S, Kolassa, IT, Stalder, T, Pfeiffer, A, Kirschbaum, C and Elbert, T (2011) Increased cortisol concentrations in hair of severely traumatized Ugandan individuals with PTSD. Psychoneuroendocrinology 36, 1193–1200.CrossRefGoogle ScholarPubMed
Tennant, R, Hiller, L, Fishwick, R, Platt, S, Joseph, S, Weich, S, Parkinson, J, Secker, J and Stewart-Brown, S (2007) The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health and Quality of Life Outcomes 5(1), 63.CrossRefGoogle ScholarPubMed
Vanaelst, B, Huybrechts, I, Bammann, K, Michels, N, Vriendt, T, Vyncke, K and Henauw, S (2012) Intercorrelations between serum, salivary, and hair cortisol and child-reported estimates of stress in elementary school girls. Psychophysiology 49(8), 1072–1081.Google ScholarPubMed
Yamada, J, Stevens, B, de Silva, N, Gibbins, S, Beyene, J, Taddio, A and Koren, G (2007) Hair cortisol as a potential biologic marker of chronic stress in hospitalized neonates. Neonatology 92(1), 42–49.CrossRefGoogle ScholarPubMed
Zigmond, AS and Snaith, RP (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67(6), 361–370.CrossRefGoogle ScholarPubMed